Company news
Schrodinger, Inc. news in 2022
Schrodinger, Inc.'s news releases, calls and decks from 2022, newest first.
Schrödinger Presents New Preclinical Data Supporting Advancement of CDC7 Inhibitor Development Candidate, SGR-2921, at American Society of Hematology 2022 Annual Meeting
December 11, 2022
Schrödinger to Present at Piper Sandler 34th Annual Healthcare Conference
November 20, 2022
Schrödinger to Present at Jefferies 13th Annual London Healthcare Conference
November 6, 2022
Schrödinger To Present New Preclinical Data From Its CDC7 Inhibitor Program At American Society Of Hematology 2022 Annual Meeting
November 2, 2022
Schrödinger Reports Third Quarter 2022 Financial Results
November 2, 2022
Schrödinger to Announce Third Quarter 2022 Financial Results on November 3
October 19, 2022
Schrödinger Hosts Platform Day
October 5, 2022
Schrödinger to Host Platform Day on October 6, 2022
September 19, 2022
Schrödinger to Present at Citi’s 17th Annual BioPharma Conference
August 30, 2022
Schrödinger Reports Inducement Grants To Newly Appointed Chief Financial Officer
August 17, 2022
Schrödinger Appoints Geoffrey Porges as Chief Financial Officer
August 17, 2022
Schrödinger Reports Second Quarter 2022 Financial Results
August 3, 2022
Schrödinger to Announce Second Quarter 2022 Financial Results on August 4
July 20, 2022
Schrödinger Announces FDA Clearance of Investigational New Drug Application for SGR-1505, a MALT1 Inhibitor
June 27, 2022
Schrödinger Convenes Global Educators For Second Annual Educator’s Day
June 21, 2022
Schrödinger to Present at Jefferies Healthcare Conference
June 1, 2022
Schrödinger Announces Appointment of Arun Oberoi to Board of Directors
May 18, 2022
Schrödinger to Present at Citi Biotech Virtual Co-Panel Day
May 12, 2022
Schrödinger Reports First Quarter 2022 Financial Results
May 3, 2022
Schrödinger to Announce First Quarter 2022 Financial Results on May 4
April 19, 2022
Schrödinger Reports New Preclinical Data Supporting Advancement of Its Wee1 Inhibitor Program at American Association of Cancer Research 2022 Annual Meeting
April 11, 2022
Schrödinger To Present New Preclinical Data From Its Wee1 Inhibitor Program At AACR Annual Meeting 2022
March 7, 2022
Schrödinger to Present at Truist Securities Life Sciences AI Symposium - Biotech & Tools
February 27, 2022
Schrödinger Reports Financial Results for the Fourth Quarter and Full Year 2021
February 23, 2022
Schrödinger to Announce Fourth Quarter and Full-Year 2021 Financial Results on February 24
February 9, 2022
Schrödinger to Present at SVB Leerink Virtual 11th Annual Global Healthcare Conference
February 7, 2022
Schrödinger Announces Acquisition of XTAL BioStructures, Inc.
January 17, 2022
Schrödinger to Present at H.C. Wainwright BioConnect Conference
January 4, 2022